Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial-Reference-Cited by-同舟云学术

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial

Published:2019-01-16 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Keilholz Ulrich,Mehnert Janice M.,Bauer Sebastian,Bourgeois Hugues,Patel Manish R.,Gravenor Donald,Nemunaitis John J.,Taylor Matthew H.,Wyrwicz Lucjan,Lee Keun-Wook,Kasturi Vijay,Chin Kevin,von Heydebreck Anja,Gulley James L.

Funder

Merck KGaA, Darmstadt, Germany

Pfizer

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-018-0459-y.pdf

Reference35 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

2. Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol. 2012;5(8):739–53.

3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

4. Hodi FS, Kluger H, Sznol M, Carvajal R, Lawrence D, Atkins M, et al. Abstract CT001: durable, long-term survival in previously treated patients with advanced melanoma (MEL) who received nivolumab (NIVO) monotherapy in a phase I trial. Cancer Res. 2016;76(14 Supplement):CT001.

5. Long GV, Eroglu Z, Infante J, Patel S, Daud A, Johnson DB, et al. Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma who received dabrafenib combined with trametinib. J Clin Oncol. 2018;36(7):667–73.

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in immunotherapy and its combination therapies for advanced melanoma: a review;Frontiers in Oncology;2024-07-16

2. Immunotherapy in melanoma: advances, pitfalls, and future perspectives;Frontiers in Molecular Biosciences;2024-06-28

3. Multifaceted roles of PD‐1 in tumorigenesis: From immune checkpoint to tumor cell‐intrinsic function;Molecular Carcinogenesis;2024-05-15

4. Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis;Scientific Reports;2024-04-03

5. The Future of Checkpoint Inhibitors in Uveal Melanoma: A Narrative Review;Ophthalmology and Therapy;2024-03-18